Murine guanylate cyclase C regulates colonic injury and inflammation

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7205-7214

  Steinbrecher, Kris A ^a,b   Harmel Laws, Eleana ^b   Garin Laflam, Monica P ^b,c   Mann, Elizabeth A ^b   Bezerra, Lucas D ^b   Hogan, Simon P ^a,b   Cohen, Mitchell B ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; GUANYLATE CYCLASE; GUANYLATE CYCLASE C; GUANYLIN; RECOMBINANT CYTOKINE; RECOMBINANT RESISTIN LIKE MOLECULE BETA; RESISTIN LIKE MOLECULE BETA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; UROGUANYLIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROLIFERATION; COLITIS; COLON INJURY; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME REGULATION; HISTOPATHOLOGY; INTESTINE EPITHELIUM CELL; MACROPHAGE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; WILD TYPE;

ANIMALS; COLONIC DISEASES; GASTROINTESTINAL HORMONES; GUANYLATE CYCLASE; HORMONES, ECTOPIC; INFLAMMATION; INTERFERON-GAMMA; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; NATRIURETIC PEPTIDES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79959537563     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1002469     Document Type: Article

References (59)

1. Cohen, M. B., and R. A. Gianella. 2002. Enterotoxigenic E. coli. In Infections of the Gastrointestinal Tract. M. J. Blaser, J. I. Ravdin, and H. B. Greenberg, eds. Raven Press, New York, p. 579-597.
2. Currie, M. G., K. F. Fok, J. Kato, R. J. Moore, F. K. Hamra, K. L. Duffin, and C. E. Smith. 1992. Guanylin: an endogenous activator of intestinal guanylate cyclase. Proc. Natl. Acad. Sci. USA 89: 947-951.
3. Hamra, F. K., L. R. Forte, S. L. Eber, N. V. Pidhorodeckyj, W. J. Krause, R. H. Freeman, D. T. Chin, J. A. Tompkins, K. F. Fok, C. E. Smith, et al. 1993. Uroguanylin: structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase. Proc. Natl. Acad. Sci. USA 90: 10464-10468.
4. Schulz, S., M. J. Lopez, M. Kuhn, and D. L. Garbers. 1997. Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice. J. Clin. Invest. 100: 1590-1595.
5. Cha, B., J. H. Kim, H. Hut, B. M. Hogema, J. Nadarja, M. Zizak, M. Cavet, W. Lee-Kwon, S. M. Lohmann, A. Smolenski, et al. 2005. cGMP inhibition of Na+/H+ antiporter 3 (NHE3) requires PDZ domain adapter NHERF2, a broad specificity protein kinase G-anchoring protein. J. Biol. Chem. 280: 16642-16650.
6. Chao, A. C., F. J. de Sauvage, Y. J. Dong, J. A. Wagner, D. V. Goeddel, and P. Gardner. 1994. Activation of intestinal CFTR Cl- channel by heat-stable enterotoxin and guanylin via cAMP-dependent protein kinase. EMBO J. 13: 1065-1072. (Pubitemid 24074713)
7. Vaandrager, A. B., A. G. Bot, P. Ruth, A. Pfeifer, F. Hofmann, and H. R. De Jonge. 2000. Differential role of cyclic GMP-dependent protein kinase II in ion transport in murine small intestine and colon. Gastroenterology 118: 108-114.
8. Cohen, M. B., A. Guarino, R. Shukla, and R. A. Giannella. 1988. Age-related differences in receptors for Escherichia coli heat-stable enterotoxin in the small and large intestine of children. Gastroenterology 94: 367-373.
9. Lorenz, J. N., M. Nieman, J. Sabo, L. P. Sanford, J. A. Hawkins, N. Elitsur, L. R. Gawenis, L. L. Clarke, and M. B. Cohen. 2003. Uroguanylin knockout mice have increased blood pressure and impaired natriuretic response to enteral NaCl load. J. Clin. Invest. 112: 1244-1254.
10. Pitari, G. M., M. D. Di Guglielmo, J. Park, S. Schulz, and S. A. Waldman. 2001. Guanylyl cyclase C agonists regulate progression through the cell cycle of human colon carcinoma cells. Proc. Natl. Acad. Sci. USA 98: 7846-7851.
11. Han, X., E. Mann, S. Gilbert, Y. Guan, K. A. Steinbrecher, M. H. Montrose, and M. B. Cohen. 2011. Loss of guanylyl cyclase C (GCC) signaling leads to dysfunctional intestinal barrier. PLoS ONE 6: e16139.
12. Vellaichamy, E., K. Kaur, and K. N. Pandey. 2007. Enhanced activation of proinflammatory cytokines in mice lacking natriuretic peptide receptor-A. Peptides 28: 893-899.
13. Keller, M., A. L. Gerbes, S. Kulhanek-Heinze, T. Gerwig, U. Grutzner, N. van Rooijen, A. M. Vollmar, and A. K. Kiemer. 2005. Hepatocyte cytoskeleton during ischemia and reperfusion-influence of ANP-mediated p38 MAPK activation. World J. Gastroenterol. 11: 7418-7429.
14. Kiemer, A. K., T. Hartung, and A. M. Vollmar. 2000. cGMP-mediated inhibition of TNF-alpha production by the atrial natriuretic peptide in murine macrophages. J. Immunol. 165: 175-181.
15. Kiemer, A. K., and A. M. Vollmar. 2001. The atrial natriuretic peptide regulates the production of inflammatory mediators in macrophages. Ann. Rheum. Dis. 60 (Suppl 3): iii68-iii70.
16. Kiemer, A. K., A. M. Vollmar, M. Bilzer, T. Gerwig, and A. L. Gerbes. 2000. Atrial natriuretic peptide reduces expression of TNF-alpha mRNA during reperfusion of the rat liver upon decreased activation of NF-kappaB and AP-1. J. Hepatol. 33: 236-246.
17. Izumi, T., Y. Saito, I. Kishimoto, M. Harada, K. Kuwahara, I. Hamanaka, N. Takahashi, R. Kawakami, Y. Li, G. Takemura, et al. 2001. Blockade of the natriuretic peptide receptor guanylyl cyclase-A inhibits NF-kappaB activation and alleviates myocardial ischemia/reperfusion injury. J. Clin. Invest. 108: 203-213.
18. Wu, F., T. Dassopoulos, L. Cope, A. Maitra, S. R. Brant, M. L. Harris, T. M. Bayless, G. Parmigiani, and S. Chakravarti. 2007. Genome-wide gene expression differences in Crohn's disease and ulcerative colitis from endoscopic pinch biopsies: insights into distinctive pathogenesis. Inflamm. Bowel Dis. 13: 807-821.
19. Borenshtein, D., R. C. Fry, E. B. Groff, P. R. Nambiar, V. J. Carey, J. G. Fox, and D. B. Schauer. 2008. Diarrhea as a cause of mortality in a mouse model of infectious colitis. Genome Biol. 9: R122.
20. Kiela, P. R., Laubitz, D., Larmonier, C. B., Midura-Kiela, M. T., Lipko, M. A., Janikashvili, N., Bai, A., Thurston, R., and Ghishan, F. K. 2009. Changes in mucosal homeostasis predispose NHE3 knockout mice to increased susceptibility to DSS-induced epithelial injury. Gastroenterology 137: 965-975, 975.e1-e10.
21. Laubitz, D., C. B. Larmonier, A. Bai, M. T. Midura-Kiela, M. A. Lipko, R. D. Thurston, P. R. Kiela, and F. K. Ghishan. 2008. Colonic gene expression profile in NHE3-deficient mice: evidence for spontaneous distal colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 295: G63-G77.
22. Woo, A. L., L. A. Gildea, L. M. Tack, M. L. Miller, Z. Spicer, D. E. Millhorn, F. D. Finkelman, D. J. Hassett, and G. E. Shull. 2002. In vivo evidence for interferon-gamma-mediated homeostatic mechanisms in small intestine of the NHE3 Na+/H+ exchanger knockout model of congenital diarrhea. J. Biol. Chem. 277: 49036-49046.
23. De Lisle, R. C. 2007. Altered transit and bacterial overgrowth in the cystic fibrosis mouse small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 293: G104-G111.
24. Norkina, O., S. Kaur, D. Ziemer, and R. C. De Lisle. 2004. Inflammation of the cystic fibrosis mouse small intestine. Am. J. Physiol. Gastrointest. Liver Physiol. 286: G1032-G1041.
25. Vij, N., S. Mazur, and P. L. Zeitlin. 2009. CFTR is a negative regulator of NFkappaB mediated innate immune response. PLoS ONE 4: e4664.
26. Verhaeghe, C., C. Remouchamps, B. Hennuy, A. Vanderplasschen, A. Chariot, S. P. Tabruyn, C. Oury, and V. Bours. 2007. Role of IKK and ERK pathways in intrinsic inflammation of cystic fibrosis airways. Biochem. Pharmacol. 73: 1982-1994.
27. Mann, E. A., M. L. Jump, J. Wu, E. Yee, and R. A. Giannella. 1997. Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion. Biochem. Biophys. Res. Commun. 239: 463-466.
28. Steinbrecher, K. A., S. A. Wowk, J. A. Rudolph, D. P. Witte, and M. B. Cohen. 2002. Targeted inactivation of the mouse guanylin gene results in altered dynamics of colonic epithelial proliferation. Am. J. Pathol. 161: 2169-2178.
29. Steinbrecher, K. A., N. A. Horowitz, E. A. Blevins, K. A. Barney, M. A. Shaw, E. Harmel-Laws, F. D. Finkelman, M. J. Flick, M. D. Pinkerton, K. E. Talmage, et al. 2010. Colitis-associated cancer is dependent on the interplay between the hemostatic and inflammatory systems and supported by integrin alpha(M)beta(2) engagement of fibrinogen. Cancer Res. 70: 2634-2643.
30. Steinbrecher, K. A., E. Harmel-Laws, R. Sitcheran, and A. S. Baldwin. 2008. Loss of epithelial RelA results in deregulated intestinal proliferative/apoptotic homeostasis and susceptibility to inflammation. J. Immunol. 180: 2588-2599.
31. Barnes, M. J., H. Aksoylar, P. Krebs, T. Bourdeau, C. N. Arnold, Y. Xia, K. Khovananth, I. Engel, S. Sovath, K. Lampe, et al. 2010. Loss of T cell and B cell quiescence precedes the onset of microbial flora-dependent wasting disease and intestinal inflammation in Gimap5-deficient mice. J. Immunol. 184: 3743-3754.
32. Li, Z., B. Taylor-Blake, A. R. Light, and M. F. Goy. 1995. Guanylin, an endogenous ligand for C-type guanylate cyclase, is produced by goblet cells in the rat intestine. Gastroenterology 109: 1863-1875.
33. McVay, L. D., S. A. Keilbaugh, T. M. Wong, S. Kierstein, M. E. Shin, M. Lehrke, M. I. Lefterova, D. E. Shifflett, S. L. Barnes, F. Cominelli, et al. 2006. Absence of bacterially induced RELMbeta reduces injury in the dextran sodium sulfate model of colitis. J. Clin. Invest. 116: 2914-2923.
34. Krimi, R. B., L. Kotelevets, L. Dubuquoy, P. Plaisancié, F. Walker, T. Lehy, P. Desreumaux, I. Van Seuningen, E. Chastre, M. E. Forgue-Lafitte, and J. C. Marie. 2008. Resistin-like molecule beta regulates intestinal mucous secretion and curtails TNBS-induced colitis in mice. Inflamm. Bowel Dis. 14: 931-941.
35. Steinbrecher, K. A., E. A. Mann, R. A. Giannella, and M. B. Cohen. 2001. Increases in guanylin and uroguanylin in a mouse model of osmotic diarrhea are guanylate cyclase C-independent. Gastroenterology 121: 1191-1202.
36. Qian, X., S. Prabhakar, A. Nandi, S. S. Visweswariah, and M. F. Goy. 2000. Expression of GC-C, a receptor-guanylate cyclase, and its endogenous ligands uroguanylin and guanylin along the rostrocaudal axis of the intestine. Endocrinology 141: 3210-3224.
37. Garin-Laflam, M. P., K. A. Steinbrecher, J. A. Rudolph, J. Mao, and M. B. Cohen. 2009. Activation of guanylate cyclase C signaling pathway protects intestinal epithelial cells from acute radiation-induced apoptosis. Am. J. Physiol. Gastrointest. Liver Physiol. 296: G740-G749.
38. Petersson, J., O. Schreiber, G. C. Hansson, S. J. Gendler, A. Velcich, J. O. Lundberg, S. Roos, L. Holm, and M. Phillipson. 2011. Importance and regulation of the colonic mucus barrier in a mouse model of colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 300: G327-G333.
39. Van der Sluis, M., B. A. De Koning, A. C. De Bruijn, A. Velcich, J. P. Meijerink, J. B. Van Goudoever, H. A. Büller, J. Dekker, I. Van Seuningen, I. B. Renes, and A. W. Einerhand. 2006. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 131: 117-129.
40. Mashimo, H., D. C. Wu, D. K. Podolsky, and M. C. Fishman. 1996. Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 274: 262-265.
41. Itoh, H., P. L. Beck, N. Inoue, R. Xavier, and D. K. Podolsky. 1999. A paradoxical reduction in susceptibility to colonic injury upon targeted transgenic ablation of goblet cells. J. Clin. Invest. 104: 1539-1547.
42. Artis, D., M. L. Wang, S. A. Keilbaugh, W. He, M. Brenes, G. P. Swain, P. A. Knight, D. D. Donaldson, M. A. Lazar, H. R. Miller, et al. 2004. RELMbeta/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc. Natl. Acad. Sci. USA 101: 13596-13600.
43. Hogan, S. P., L. Seidu, C. Blanchard, K. Groschwitz, A. Mishra, M. L. Karow, R. Ahrens, D. Artis, A. J. Murphy, D. M. Valenzuela, et al. 2006. Resistin-like molecule beta regulates innate colonic function: barrier integrity and inflammation susceptibility. J. Allergy Clin. Immunol. 118: 257-268.
44. Möndel, M., B. O. Schroeder, K. Zimmermann, H. Huber, S. Nuding, J. Beisner, K. Fellermann, E. F. Stange, and J. Wehkamp. 2009. Probiotic E. coli treatment mediates antimicrobial human beta-defensin synthesis and fecal excretion in humans. Mucosal Immunol. 2: 166-172.
45. Nava, P., S. Koch, M. G. Laukoetter, W. Y. Lee, K. Kolegraff, C. T. Capaldo, N. Beeman, C. Addis, K. Gerner-Smidt, I. Neumaier, et al. 2010. Interferon-gamma regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity 32: 392-402.
46. Wang, F., W. V. Graham, Y. Wang, E. D. Witkowski, B. T. Schwarz, and J. R. Turner. 2005. Interferon-gamma and tumor necrosis factor-alpha synergize to induce intestinal epithelial barrier dysfunction by up-regulating myosin light chain kinase expression. Am. J. Pathol. 166: 409-419.
47. Wang, F., B. T. Schwarz, W. V. Graham, Y. Wang, L. Su, D. R. Clayburgh, C. Abraham, and J. R. Turner. 2006. IFN-gamma-induced TNFR2 expression is required for TNF-dependent intestinal epithelial barrier dysfunction. Gastroenterology 131: 1153-1163.
48. Kuhn, M. 2009. Function and dysfunction of mammalian membrane guanylyl cyclase receptors: lessons from genetic mouse models and implications for human diseases. Handb. Exp. Pharmacol. 191: 47-69.
49. Whitaker, T. L., K. A. Steinbrecher, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, and M. B. Cohen. 1997. The uroguanylin gene (Guca1b) is linked to guanylin (Guca2) on mouse chromosome 4. Genomics 45: 348-354.
50. Barnes, S. L., A. Vidrich, M. L. Wang, G. D. Wu, F. Cominelli, J. Rivera-Nieves, G. Bamias, and S. M. Cohn. 2007. Resistin-like molecule beta (RELMbeta/FIZZ2) is highly expressed in the ileum of SAMP1/YitFc mice and is associated with initiation of ileitis. J. Immunol. 179: 7012-7020.
51. Nair, M. G., K. J. Guild, Y. Du, C. Zaph, G. D. Yancopoulos, D. M. Valenzuela, A. Murphy, S. Stevens, M. Karow, and D. Artis. 2008. Goblet cell-derived resistin-like molecule beta augments CD4+ T cell production of IFN-gamma and infection-induced intestinal inflammation. J. Immunol. 181: 4709-4715.
52. Grivennikov, S., E. Karin, J. Terzic, D. Mucida, G. Y. Yu, S. Vallabhapurapu, J. Scheller, S. Rose-John, H. Cheroutre, L. Eckmann, and M. Karin. 2009. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15: 103-113.
53. Nathan, C. 2006. Neutrophils and immunity: challenges and opportunities. Nat. Rev. Immunol. 6: 173-182.
54. Shea-Donohue, T., K. Thomas, M. J. Cody, L. J. Aiping Zhao, K. M. Detolla, M. Kopydlowski, S. A. Fukata, Lira, and S. N. Vogel. 2008. Mice deficient in the CXCR2 ligand, CXCL1 (KC/GRO-alpha), exhibit increased susceptibility to dextran sodium sulfate (DSS)-induced colitis. Innate Immun. 14: 117-124.
55. Qualls, J. E., A. M. Kaplan, N. van Rooijen, and D. A. Cohen. 2006. Suppression of experimental colitis by intestinal mononuclear phagocytes. J. Leukoc. Biol. 80: 802-815.
56. Qualls, J. E., H. Tuna, A. M. Kaplan, and D. A. Cohen. 2009. Suppression of experimental colitis in mice by CD11c+ dendritic cells. Inflamm. Bowel Dis. 15: 236-247.
57. Arrieta, M. C., K. Madsen, J. Doyle, and J. Meddings. 2009. Reducing small intestinal permeability attenuates colitis in the IL10 gene-deficient mouse. Gut 58: 41-48.
58. Johnston, J. M., C. B. Kurtz, D. A. Drossman, A. J. Lembo, B. I. Jeglinski, J. E. MacDougall, S. M. Antonelli, and M. G. Currie. 2009. Pilot study on the effect of linaclotide in patients with chronic constipation. Am. J. Gastroenterol. 104: 125-132.
59. Johnston, J. M., Kurtz, C. B., Macdougall, J. E., Lavins, B. J., Currie, M. G., Fitch, D. A., O'Dea, C., Baird, M., and Lembo, A. J. Linaclotide improves abdominal pain and bowel habits in a phase IIb study of patients with irritable bowel syndrome with constipation. Gastroenterology 139: 1877-1886.